Exenatide does not slow Parkinson’s disease progression compared to placebo
1. There was no significant difference in functional outcome between both groups at 96 weeks. 2. Exenatide was safe and ...
1. There was no significant difference in functional outcome between both groups at 96 weeks. 2. Exenatide was safe and ...
1. In a diverse population with universal access to health care, tremor and impaired memory symptoms prior to diagnosis had ...
1. Newly diagnosed Parkinson Disease patients who were active had an associated reduced all-cause mortality compared to those who were ...
1. Among a cohort of individuals from South Korea, exposure to nitrogen dioxide (NO2) was found to be associated with ...
2 Minute Medicine® is an award winning, physician-run, expert medical media company. Our content is curated, written and edited by practicing health professionals who have clinical and scientific expertise in their field of reporting. Our editorial management team is comprised of highly-trained MD physicians. Join numerous brands, companies, and hospitals who trust our licensed content.
© 2021 2 Minute Medicine, Inc. - Physician-written medical news.
© 2021 2 Minute Medicine, Inc. - Physician-written medical news.